☆Stonepine Capital Management, LLC
Quality Q
0.090
AUM ($M)
131
Positions
72
Turnover
0.28
Top-10 wt
55%
Herfindahl
0.042
History (qtrs)
6
Excess Return
not eligible
AI Eval Run AI Eval
Holdings · 93 positions · portfolio value $168M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆VSTM funds › | VERASTEM INC | ADD | — | 7.6% | -7.8% | 12.8 | 3,349,627 | +47,327 | 5 | — |
| ☆EOLS funds › | EVOLUS INC | TRIM | — | 6.6% | +0.2% | 11.0 | 1,590,162 | -168,929 | 5 | — |
| ☆AYTU funds › | AYTU BIOPHARMA INC | ADD | — | 5.7% | +3.8% | 9.6 | 4,990,238 | +4,197,949 | 5 | — |
| ☆TENX funds › | TENAX THERAPEUTICS INC | TRIM | — | 5.7% | -8.0% | 9.6 | 660,000 | -315,200 | 3 | — |
| ☆NKTR funds › | NEKTAR THERAPEUTICS | ADD | — | 5.0% | -0.4% | 8.4 | 120,654 | +35,654 | 5 | — |
| ☆AZTR funds › | AZITRA INC | NEW | — | 4.8% | +4.8% | 8.0 | 81,797,553 | +81,797,553 | 1 | — |
| ☆CNSP funds › | CNS PHARMACEUTICALS INC | ADD | — | 3.8% | +3.7% | 6.4 | 1,345,921 | +1,284,921 | 3 | — |
| ☆ELOX funds › | ELOXX PHARMACEUTICALS INC | NEW | — | 3.7% | +3.7% | 6.2 | 447,160 | +447,160 | 1 | — |
| ☆ADMA funds › | ADMA BIOLOGICS INC | HOLD | Common Stock | 3.7% | -2.2% | 6.2 | 740,000 | +0 | 5 | — |
| ☆CAMP funds › | CAMP4 THERAPEUTICS CORP | HOLD | — | 3.6% | -1.8% | 6.1 | 1,389,622 | +0 | 3 | — |
| ☆KZIA funds › | KAZIA THERAPEUTICS LTD | HOLD | — | 2.9% | +0.6% | 4.9 | 345,179 | +0 | 3 | — |
| ☆SRZN funds › | SURROZEN INC | ADD | — | 2.8% | +2.0% | 4.7 | 68,001 | +34,996 | 5 | — |
| ☆INDV funds › | INDIVIOR PHARMACEUTICALS INC | NEW | — | 2.4% | +2.4% | 4.1 | 100,000 | +100,000 | 1 | — |
| ☆CRBP funds › | CORBUS PHARMACEUTICALS HLDGS | ADD | — | 2.4% | -0.8% | 4.0 | 425,000 | +41,538 | 3 | — |
| ☆MSLE funds › | SATELLOS BIOSCIENCE INC | ADD | — | 2.2% | +1.7% | 3.7 | 491,624 | +391,624 | 2 | — |
| ☆ZVRA funds › | ZEVRA THERAPEUTICS INC | TRIM | — | 2.2% | -1.7% | 3.7 | 258,701 | -221,299 | 5 | — |
| ☆ABEO funds › | ABEONA THERAPEUTICS INC | TRIM | — | 2.1% | -0.9% | 3.4 | 557,284 | -189,303 | 5 | — |
| ☆EDSA funds › | EDESA BIOTECH INC | ADD | — | 1.9% | +1.8% | 3.2 | 456,439 | +426,439 | 4 | — |
| ☆CUSIP:231269309 funds › | CURIS INC | ADD | — | 1.9% | +0.1% | 3.2 | 14,312,187 | +10,585,781 | 3 | — |
| ☆CABA funds › | CABALETTA BIO INC | ADD | — | 1.7% | +1.6% | 2.9 | 917,100 | +867,100 | 3 | — |
| ☆ANTX funds › | AN2 THERAPEUTICS INC | TRIM | — | 1.6% | -0.6% | 2.7 | 551,692 | -162,153 | 5 | — |
| ☆IKT funds › | INHIBIKASE THERAPEUTICS INC | ADD | — | 1.4% | +0.0% | 2.4 | 2,468,595 | +1,511,393 | 5 | — |
| ☆INAB funds › | IN8BIO INC | ADD | — | 1.4% | +0.5% | 2.3 | 1,624,562 | +961,150 | 5 | — |
| ☆XLO funds › | XILIO THERAPEUTICS INC | ADD | — | 1.3% | +0.8% | 2.2 | 225,994 | +161,832 | 2 | — |
| ☆ACET funds › | ADICET BIO INC | ADD | — | 1.3% | -0.1% | 2.1 | 245,518 | +23,563 | 3 | — |
| ☆QNRX funds › | QUOIN PHARMACEUTICALS LTD | ADD | — | 1.2% | +0.9% | 2.0 | 765,546 | +712,086 | 3 | — |
| ☆TELA funds › | TELA BIO INC | ADD | — | 1.2% | -0.2% | 2.0 | 2,662,427 | +45,175 | 5 | — |
| ☆ADIL funds › | ADIAL PHARMACEUTICALS INC | NEW | — | 0.9% | +0.9% | 1.6 | 727,563 | +727,563 | 1 | — |
| ☆SPRB funds › | SPRUCE BIOSCIENCES INC | NEW | — | 0.9% | +0.9% | 1.6 | 28,795 | +28,795 | 1 | — |
| ☆OKYO funds › | OKYO PHARMA LTD | ADD | — | 0.8% | -0.4% | 1.3 | 862,996 | +12,996 | 2 | — |
| ☆CALC funds › | CALCIMEDICA INC | NEW | — | 0.8% | +0.8% | 1.3 | 2,128,597 | +2,128,597 | 1 | — |
| ☆KTTA funds › | PASITHEA THERAPEUTICS CORP | ADD | — | 0.7% | +0.1% | 1.1 | 2,201,468 | +1,370,167 | 3 | — |
| ☆SLGL funds › | SOL-GEL TECHNOLOGIES LTD | TRIM | — | 0.6% | -1.3% | 1.1 | 14,469 | -13,309 | 2 | — |
| ☆LUNG funds › | PULMONX CORP | ADD | — | 0.6% | -0.2% | 1.1 | 815,436 | +47,148 | 5 | — |
| ☆XFOR funds › | X4 PHARMACEUTICALS INC | TRIM | — | 0.6% | -0.6% | 1.1 | 224,989 | -110,320 | 4 | — |
| ☆MLTX funds › | MOONLAKE IMMUNOTHERAPEUTICS | NEW | — | 0.6% | +0.6% | 1.0 | 50,000 | +50,000 | 1 | — |
| ☆HELP funds › | CYBIN INC | ADD | — | 0.6% | +0.0% | 1.0 | 330,530 | +196,470 | 3 | — |
| ☆MXCT funds › | MAXCYTE INC | TRIM | — | 0.6% | -0.1% | 0.9 | 751,606 | -253,067 | 4 | — |
| ☆PHAT funds › | PHATHOM PHARMACEUTICALS INC | ADD | — | 0.5% | +0.1% | 0.9 | 85,010 | +35,000 | 2 | — |
| ☆CNTB funds › | CONNECT BIOPHARMA HLDGS LTD | ADD | — | 0.5% | -0.2% | 0.9 | 364,254 | +54,254 | 2 | — |
| ☆RARE funds › | ULTRAGENYX PHARMACEUTICAL IN | NEW | — | 0.5% | +0.5% | 0.8 | 25,000 | +25,000 | 1 | — |
| ☆RADX funds › | RADIOPHARM THERANOSTICS LTD | ADD | — | 0.5% | -0.2% | 0.8 | 102,000,000 | +51,000,000 | 3 | — |
| ☆ZNTL funds › | ZENTALIS PHARMACEUTICALS INC | TRIM | — | 0.5% | -0.1% | 0.8 | 161,583 | -107,517 | 5 | — |
| ☆CTMX funds › | CYTOMX THERAPEUTICS INC. | ADD | — | 0.5% | -0.4% | 0.8 | 205,000 | +5,000 | 2 | — |
| ☆NGEN funds › | NERVGEN PHARMA CORP | NEW | — | 0.4% | +0.4% | 0.7 | 571,678 | +571,678 | 1 | — |
| ☆NVCT funds › | NUVECTIS PHARMA INC | NEW | — | 0.4% | +0.4% | 0.7 | 40,000 | +40,000 | 1 | — |
| ☆CBIO funds › | CRESCENT BIOPHARMA INC. | TRIM | — | 0.4% | -0.9% | 0.7 | 40,000 | -45,000 | 3 | — |
| ☆PMVP funds › | PMV PHARMACEUTICALS INC | TRIM | — | 0.4% | -0.3% | 0.7 | 536,086 | -172,016 | 5 | — |
| ☆ORKA funds › | ORUKA THERAPEUTICS INC | NEW | — | 0.4% | +0.4% | 0.7 | 7,500 | +7,500 | 1 | — |
| ☆OKUR funds › | ONKURE THERAPEUTICS INC | TRIM | — | 0.4% | -0.1% | 0.6 | 130,684 | -1,894 | 2 | — |
| ☆SINT funds › | SINTX TECHNOLOGIES INC | NEW | — | 0.3% | +0.3% | 0.6 | 627,615 | +627,615 | 1 | — |
| ☆IMA funds › | IMAGENEBIO INC | NEW | — | 0.3% | +0.3% | 0.5 | 96,172 | +96,172 | 1 | — |
| ☆ARVN funds › | ARVINAS INC | ADD | — | 0.3% | +0.0% | 0.5 | 60,000 | +32,500 | 2 | — |
| ☆BIOA funds › | BIOAGE LABS INC | TRIM | — | 0.3% | -0.5% | 0.5 | 20,000 | -30,000 | 5 | — |
| ☆IRD funds › | OPUS GENETICS INC | ADD | — | 0.2% | -0.0% | 0.4 | 100,718 | +32,030 | 2 | — |
| ☆QTI funds › | QT IMAGING HLDGS INC | NEW | — | 0.2% | +0.2% | 0.4 | 100,000 | +100,000 | 1 | — |
| ☆BOLD funds › | BOUNDLESS BIO INC | TRIM | — | 0.2% | -0.3% | 0.4 | 154,595 | -443,087 | 5 | — |
| ☆MLSS funds › | MILESTONE PHARMACEUTICALS IN | NEW | — | 0.2% | +0.2% | 0.3 | 666,666 | +666,666 | 1 | — |
| ☆CLRB funds › | CELLECTAR BIOSCIENCES INC | NEW | — | 0.2% | +0.2% | 0.3 | 104,550 | +104,550 | 1 | — |
| ☆EPRX funds › | EUPRAXIA PHARMACEUTICALS INC | NEW | — | 0.2% | +0.2% | 0.3 | 43,491 | +43,491 | 1 | — |
| ☆SABS funds › | SAB BIOTHERAPEUTICS INC | ADD | — | 0.2% | +0.0% | 0.3 | 73,271 | +23,271 | 2 | — |
| ☆ANL funds › | ADLAI NORTYE LTD | NEW | — | 0.2% | +0.2% | 0.3 | 24,257 | +24,257 | 1 | — |
| ☆SENS funds › | SENSEONICS HLDGS INC | NEW | — | 0.2% | +0.2% | 0.3 | 48,680 | +48,680 | 1 | — |
| ☆PLRX funds › | PLIANT THERAPEUTICS INC | ADD | — | 0.2% | -0.1% | 0.3 | 230,538 | +5,888 | 4 | — |
| ☆CDXS funds › | CODEXIS INC | TRIM | — | 0.1% | -0.5% | 0.2 | 109,662 | -308,332 | 4 | — |
| ☆VRCA funds › | VERRICA PHARMACEUTICALS INC | TRIM | — | 0.1% | -0.3% | 0.2 | 88,417 | -11,318 | 3 | — |
| ☆POCI funds › | PRECISION OPTICS CORP INC MA | TRIM | — | 0.1% | -0.2% | 0.2 | 46,390 | -53,610 | 2 | — |
| ☆UPB funds › | UPSTREAM BIO INC | TRIM | — | 0.1% | -0.1% | 0.2 | 33,432 | -1,568 | 2 | — |
| ☆RNTX funds › | REIN THERAPEUTICS INC | NEW | — | 0.1% | +0.1% | 0.2 | 218,038 | +218,038 | 1 | — |
| ☆INO funds › | INOVIO PHARMACEUTICALS INC | NEW | — | 0.1% | +0.1% | 0.2 | 1,345,237 | +1,345,237 | 1 | — |
| ☆HRTX funds › | HERON THERAPEUTICS INC | TRIM | — | 0.1% | -0.9% | 0.2 | 490,787 | -911,404 | 5 | — |
| ☆HUMA funds › | HUMACYTE INC | NEW | — | 0.1% | +0.1% | 0.2 | 231,299 | +231,299 | 1 | — |
| ☆DTIL funds › | PRECISION BIOSCIENCES INC | NEW | — | 0.1% | +0.1% | 0.1 | 40,000 | +40,000 | 1 | — |
| ☆KLRS funds › | KALARIS THERAPEUTICS INC | ADD | — | 0.1% | -0.0% | 0.1 | 30,122 | +9,722 | 2 | — |
| ☆TNYA funds › | TENAYA THERAPEUTICS INC | NEW | — | 0.1% | +0.1% | 0.1 | 352,001 | +352,001 | 1 | — |
| ☆PCSA funds › | PROCESSA PHARMACEUTICALS INC | HOLD | — | 0.1% | -0.1% | 0.1 | 55,000 | +0 | 3 | — |
| ☆BCAB funds › | BIOATLA INC | NEW | — | 0.0% | +0.0% | 0.1 | 16,432 | +16,432 | 1 | — |
| ☆CGEN funds › | COMPUGEN LTD | TRIM | — | 0.0% | -0.2% | 0.1 | 31,387 | -72,913 | 3 | — |
| ☆GRCE funds › | GRACE THERAPEUTICS INC | NEW | — | 0.0% | +0.0% | 0.1 | 294,550 | +294,550 | 1 | — |
| ☆OVID funds › | OVID THERAPEUTICS INC | TRIM | — | 0.0% | -0.0% | 0.1 | 21,300 | -18,700 | 3 | — |
| ☆CUSIP:29970R303 funds › | EVAXION AS | TRIM | — | 0.0% | -0.0% | 0.1 | 17,562 | -2,151 | 3 | — |
| ☆XOMA funds › | XOMA ROYALTY CORPORATION | EXIT | — | 0.0% | -1.9% | 0.0 | 0 | -69,500 | 0 | — |
| ☆CADL funds › | CANDEL THERAPEUTICS INC | EXIT | — | 0.0% | -0.4% | 0.0 | 0 | -102,500 | 0 | — |
| ☆JANX funds › | JANUX THERAPEUTICS INC | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -20,000 | 0 | — |
| ☆SIBN funds › | SI BONE INC | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -14,964 | 0 | — |
| ☆NMRA funds › | NEUMORA THERAPEUTICS INC. | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -100,000 | 0 | — |
| ☆CUSIP:09077B104 funds › | BIOATLA INC | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -65,387 | 0 | — |
| ☆MNKD funds › | MANNKIND CORP | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -16,300 | 0 | — |
| ☆APRE funds › | APREA THERAPEUTICS INC | NEW | — | 0.0% | +0.0% | 0.0 | 137,174 | +137,174 | 0 | — |
| ☆XERS funds › | XERIS BIOPHARMA HOLDINGS INC | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -40,030 | 0 | — |
| ☆ELDN funds › | ELEDON PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -35,000 | 0 | — |
| ☆OABI funds › | OMNIAB INC | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -164,045 | 0 | — |
| ☆ESTA funds › | ESTABLISHMENT LABS HLDGS INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -6,000 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 168 | 82 | 0.36 | 50% | 0.034 | 0.047 | — | in |
| 2026Q1 | 114 | 66 | 0.36 | 64% | 0.064 | 0.071 | — | in |
| 2025Q4 | 126 | 61 | 0.30 | 57% | 0.059 | 0.075 | — | in |
| 2025Q3 | 123 | 58 | 0.35 | 62% | 0.066 | 0.059 | — | in |
| 2025Q2 | 102 | 58 | 0.49 | 59% | 0.049 | 0.018 | — | entered |
| 2025Q1 | 103 | 66 | 0.00 | 58% | 0.056 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status